Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -60.08% | -29.72% | 1.12% | -80.09% | 170.47% |
| Total Other Revenue | -- | -- | -- | -- | -100.00% |
| Total Revenue | 76.76% | -77.32% | -93.87% | -89.25% | -95.80% |
| Cost of Revenue | -44.18% | -91.16% | -84.87% | -90.79% | -91.40% |
| Gross Profit | 214.95% | -65.35% | -94.65% | -87.70% | -118.00% |
| SG&A Expenses | -63.62% | -55.40% | -23.10% | -23.48% | 12.10% |
| Depreciation & Amortization | -25.06% | -23.86% | -13.86% | -15.18% | 14.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.28% | -34.17% | -20.47% | -19.81% | -21.61% |
| Operating Income | 35.67% | 31.47% | -4.92% | 16.64% | -0.69% |
| Income Before Tax | -137.51% | 27.09% | -1.84% | 19.03% | -1.82% |
| Income Tax Expenses | -5,676.83% | -5,354.95% | -40.29% | -47.37% | -100.21% |
| Earnings from Continuing Operations | -133.39% | 39.29% | -1.72% | 19.10% | 24.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -133.39% | 39.29% | -1.72% | 19.10% | 24.84% |
| EBIT | 35.67% | 31.47% | -4.92% | 16.64% | -0.69% |
| EBITDA | 36.00% | 31.74% | -5.79% | 16.69% | -0.33% |
| EPS Basic | -27.52% | 51.14% | 7.45% | 24.67% | 28.27% |
| Normalized Basic EPS | 65.93% | 42.98% | 1.07% | 20.22% | 0.79% |
| EPS Diluted | -26.73% | 50.00% | 7.45% | 23.09% | 27.95% |
| Normalized Diluted EPS | 65.93% | 42.98% | 1.07% | 20.22% | 0.79% |
| Average Basic Shares Outstanding | 83.03% | 24.25% | 9.90% | 7.39% | 4.79% |
| Average Diluted Shares Outstanding | 83.03% | 24.25% | 9.90% | 7.39% | 4.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |